DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Aakaar Medical Technologies Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 2 hrs ago·17 Oct 2026, 5:35 am

Aakaar Medical Technologies

Aakaar Medical Technologies Limited has announced the schedule for its upcoming analyst and institutional investor meet. This event is a standard platform for the company to engage with market participants and present its business strategy.

For investors, such meetings provide a direct opportunity to gain insights into the company's future plans, operational progress, and financial outlook. It helps clarify the management's vision, which can be crucial for making informed investment decisions.

Investors should watch for key updates regarding the company's growth trajectory, product pipeline, and any guidance provided during the interaction. This information will be vital for assessing the company's potential in the medical technology sector.